Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
established that alpha-MSH C-terminal fragments, including the KPV sequence, reduce contact hypersensitivity and produce meaningful anti-inflammatory effects in dermal models.6 Conditions Under Investigation In preclinical models, KPV has shown relevance to: Eczema and atopic dermatitis conditions driven by dysregulated Th2 immune responses and skin barrier failure Psoriasis characterized by keratinocyte hyperproliferation and NF-B overactivation Contact hypersensitivity where KPV's ability to modulate immune cell activation in dermal tissue has been demonstrated directly Wound healing where suppression of excess inflammation supports tissue repair rather than hindering it No large-scale human trials exist for dermatological applications yet
The 4-week minimum at each dose level is not arbitrary
We adhere to the management principles of "quality first, customer first and credit-based" since the establishment of the company and always do our best to satisfy potential needs of our customers
Hsieh et al., Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation, J
Gastric and intestinal protection is another major research area as a gastric-derived peptide, BPC-157 has been extensively explored for protective effects on the gastrointestinal lining
US$ 24.67
US$ 29.86
US$ 21.08
US$ 25.83
US$ 21.76
US$ 25.60
US$ 20.14
US$ 22.07
US$ 23.48
US$ 25.94